Heliyon (Mar 2024)

Pyruvate kinase deficiency and PKLR gene mutations: Insights from molecular dynamics simulation analysis

  • Yang Wang,
  • Jiaqi Liu,
  • Tao Liu,
  • Xizhou An,
  • Lan Huang,
  • Jiacheng Li,
  • Yongjie Zhang,
  • Yan Xiang,
  • Li Xiao,
  • Weijia Yi,
  • Jiebin Qin,
  • Lili Liu,
  • Cuilan Wang,
  • Jie Yu

Journal volume & issue
Vol. 10, no. 5
p. e26368

Abstract

Read online

Pyruvate kinase deficiency is a rare hereditary erythrocyte enzyme disease caused by mutations in the pyruvate kinase liver and red blood cell gene. The clinical presentations of pyruvate kinase deficiency are significantly heterogeneous, ranging from just mild anemia to hemolytic crisis or even death. The proband in our study was a 2-year-old girl for severe skin and scleral icterus with progressive aggravation. We collected the family's data for further analysis. Whole exome genome sequencing of the pedigree revealed a novel compound heterozygous mutation, c.1097del (p.P366Lfs*12) and c.1493G > A (p.R498H), in the pyruvate kinase liver and red blood cell gene. Furthermore, molecular dynamics simulations were employed to uncover differences between the wild type and mutant pyruvate kinase liver and red blood cell proteins, focusing on structural stability, protein flexibility, secondary structure, and overall conformation. The combined bioinformatic tools were also utilised to assess the effects of the missense mutation on protein function. Thereafter, wild type and mutant plasmids were constructed and transfected into 293T cells, and Western blot assay was conducted to validate the impact of the mutations on the expression of pyruvate kinase liver and red blood cell protein. The data presented in our study enriches the genotype database and provides evidence for genetic counseling and molecular diagnosis of pyruvate kinase deficiency.

Keywords